Opioid maker Purdue’s bankruptcy case comes before Supreme Court
SCOTUSBlog
DECEMBER 2, 2023
The company conducted an aggressive marketing campaign for the drug, selling it as a relief option for a broad array of pain, from cancer to long-lasting sports injuries, and generating some $35 billion in revenue. But at the very least, they “will have to spend time and money litigating that disputed question.” In any event, the U.S.
139 
Let's personalize your content